Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 55127

1.

Anti-CGRP monoclonal antibodies in migraine: current perspectives.

Giamberardino MA, Affaitati G, Curto M, Negro A, Costantini R, Martelletti P.

Intern Emerg Med. 2016 Jun 23. [Epub ahead of print] Review.

PMID:
27339365
2.

Risk Prediction Models in Psychiatry: Toward a New Frontier for the Prevention of Mental Illnesses.

Bernardini F, Attademo L, Cleary SD, Luther C, Shim RS, Quartesan R, Compton MT.

J Clin Psychiatry. 2016 Jun 21. doi: 10.4088/JCP.15r10003. [Epub ahead of print]

PMID:
27337225
3.

Disparities Within Serious Mental Illness [Internet].

Evans TS, Berkman N, Brown C, Gaynes B, Weber RP.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2016 May.

4.

Early interventions in risk groups for schizophrenia: what are we waiting for?

Sommer IE, Bearden CE, van Dellen E, Breetvelt EJ, Duijff SN, Maijer K, van Amelsvoort T, de Haan L, Gur RE, Arango C, Díaz-Caneja CM, Vinkers CH, Vorstman JA.

NPJ Schizophr. 2016 Mar 9;2:16003. doi: 10.1038/npjschz.2016.3. eCollection 2016. Review.

PMID:
27336054
5.

Metabolic Disturbances, Side Effect Profile and Effectiveness of Clozapine in Adolescents.

Grover S, Hazari N, Chakrabarti S, Avasthi A.

Indian J Psychol Med. 2016 May-Jun;38(3):224-33. doi: 10.4103/0253-7176.183091.

PMID:
27335518
6.

Prolactin levels in drug-naïve patients with schizophrenia and other psychotic disorders.

Petrikis P, Tigas S, Tzallas AT, Archimandriti DT, Skapinakis P, Mavreas V.

Int J Psychiatry Clin Pract. 2016 Jun 23:1-5. [Epub ahead of print]

PMID:
27334805
7.

The association between ethnic background and characteristics of first mental health treatment for psychotic disorders in the Netherlands between 2001 and 2005.

Fassaert T, Heijnen H, de Wit MA, Peen J, Beekman AT, Dekker J.

Soc Psychiatry Psychiatr Epidemiol. 2016 Jun 22. [Epub ahead of print]

PMID:
27333981
8.

Psychotic spectrum symptoms across the lifespan are related to lifetime suicidality among 147 patients with bipolar I or major depressive disorder.

Gesi C, Carmassi C, Miniati M, Benvenuti A, Massimetti G, Dell'Osso L.

Ann Gen Psychiatry. 2016 Jun 21;15:15. doi: 10.1186/s12991-016-0101-7. eCollection 2016.

9.

Cortical GABA markers identify a molecular subtype of psychotic and bipolar disorders.

Volk DW, Sampson AR, Zhang Y, Edelson JR, Lewis DA.

Psychol Med. 2016 Jun 22:1-12. [Epub ahead of print]

PMID:
27328999
10.

Patients receiving lithium therapy have a reduced prevalence of neurological and cardiovascular disorders.

Prosser JM, Fieve RR.

Prog Neuropsychopharmacol Biol Psychiatry. 2016 Jun 17. pii: S0278-5846(16)30085-9. doi: 10.1016/j.pnpbp.2016.06.006. [Epub ahead of print]

PMID:
27328427
11.

Psychosis of epilepsy: a multifaceted neuropsychiatric disorder.

Kanner AM, Rivas-Grajales AM.

CNS Spectr. 2016 Jun;21(3):247-57. doi: 10.1017/S1092852916000250.

PMID:
27322691
12.

[Leisure-time activity for patients with a psychotic disorder: audiobooks as a useful alternative to reading].

Herpers SA, Rasing SP, Postulart D, Rooijmans P.

Tijdschr Psychiatr. 2016;58(6):476-80. Dutch.

13.

[Metacognition in psychotic disorders: from concepts to intervention].

de Jong S, van Donkersgoed RJ, Arends J, Lysaker PH, Wunderink L, van der Gaag M, Aleman A, Pijnenborg GH.

Tijdschr Psychiatr. 2016;58(6):455-62. Dutch.

14.

Lifetime prevalence, sociodemographic correlates, and diagnostic overlaps of bipolar spectrum disorder in the general population of South Korea.

Kim JH, Chang SM, Hong JP, Bae JN, Cho SJ, Hahm BJ, Lee DW, Park JI, Lee JY, Jeon HJ, Kim BS, Cho MJ.

J Affect Disord. 2016 Jun 7;203:248-255. doi: 10.1016/j.jad.2016.06.017. [Epub ahead of print]

PMID:
27314811
15.

Psychosis or Obsessions? Clozapine Associated with Worsening Obsessive-Compulsive Symptoms.

Leung JG, Palmer BA.

Case Rep Psychiatry. 2016;2016:2180748. doi: 10.1155/2016/2180748. Epub 2016 May 30.

16.

Psychosis in Parkinson's Disease: Epidemiology, Pathophysiology, and Management.

Chang A, Fox SH.

Drugs. 2016 Jun 16. [Epub ahead of print] Review.

PMID:
27312429
17.

Increased serum brain-derived neurotrophic factor levels following electroconvulsive therapy or antipsychotic treatment in patients with schizophrenia.

Li J, Ye F, Xiao W, Tang X, Sha W, Zhang X, Wang J.

Eur Psychiatry. 2016 Jun 13;36:23-28. doi: 10.1016/j.eurpsy.2016.03.005. [Epub ahead of print]

PMID:
27311104
18.

Early-life metal exposure and schizophrenia: A proof-of-concept study using novel tooth-matrix biomarkers.

Modabbernia A, Velthorst E, Gennings C, De Haan L, Austin C, Sutterland A, Mollon J, Frangou S, Wright R, Arora M, Reichenberg A.

Eur Psychiatry. 2016 Jun 13;36:1-6. doi: 10.1016/j.eurpsy.2016.03.006. [Epub ahead of print]

PMID:
27311101
19.

Do the Trajectories of Bipolar Disorder and Schizophrenia Follow a Universal Staging Model?

Duffy A, Malhi GS, Grof P.

Can J Psychiatry. 2016 May 4. pii: 0706743716649189. [Epub ahead of print]

PMID:
27310243
20.

Perceived Stigma among Recipients of Mental Health Care in the General Canadian Population.

Patten SB, Williams JV, Lavorato DH, Bulloch AG, Charbonneau M, Gautam M, Moss P, Abbey S, Stuart H.

Can J Psychiatry. 2016 Mar 18. pii: 0706743716639928. [Epub ahead of print]

PMID:
27310227
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk